• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Neurotechnology Industry Report Says Revenues Grew 10% to $120.5 Billion

Posted on: Monday, 11 June 2007, 12:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c59269) has announced the addition of "The Neurotechnology Industry 2007 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System" published by NeuroInsights to their offering.

NeuroInsights, the neurotechnology market authority, announced the release of the organization's third annual comprehensive investment and market analysis of the global neurotech industry. Unveiled during the annual Neurotechnology Industry Conference, this 350-page report features important industry data and analysis to help investors, companies and governments easily quantify opportunities, determine risks and understand the dynamics of this rapidly changing market.

"The Neurotechnology Industry 2007 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System" is a market analysis and strategic investment guide of the global neurological disease and psychiatric illness markets. The report focuses on the more than 500 public and private companies translating advances in neuroscience into tomorrow's treatments. It provides insight and analysis of issues such as corporate financing, market activity, growth drivers and global industry conditions that make up the obstacles and opportunities facing the industry. The report provides an in-depth look at fifteen brain and central nervous system disorders, including Alzheimer's disease, addiction, anxiety, attention disorders, depression, epilepsy, hearing loss, insomnia, memory decline, obesity, pain, Parkinson's, sensory disorders, stroke and other brain-related illnesses.

Specific findings from the Neurotechnology Industry 2007 Report include:

Brain-related illnesses afflict more than two billion people worldwide

The worldwide economic burden of this problem has reached more than $2 trillion per year; more than $1 trillion in the U.S. alone

2006 venture capital investment in neurotechnology rose 7.5% to $1.666 billion

Neurotech industry revenues rose 10% in 2006 to $120.5 billion; this includes neuropharmaceutical revenues of $101 billion, neurodevice revenues of $4.5 billion, neurodiagnostic revenues of $15 billion

The NeuroInsights' Neurotech Index of publicly-traded neurotechnology companies was up 53% from its December 31, 2003 conception to March 31, 2006, outpacing, the NASDAQ Biotech Index which gained 7% during the same period

"This report is a go-to guide for business development executives, investors, and entrepreneurs. This is the only CNS report providing a comprehensive picture of the global commercial neuroscience industry improving identification of market and partnering opportunities and immeasurably increasing due diligence capabilities," said Casey Lynch Managing Director of NeuroInsights. "Each year NeuroInsights builds on concrete knowledge of deals, product development, and scientific advances to bring the most accurate and up to date information to the industry."

New findings from the report were discussed during NeuroInsights' annual Neurotech Industry Investing and Partnering Conference. The conference is a global forum for investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system to come together to shape the future of their organization and the industry.

About NeuroInsights

As the neurotechnology market authority, NeuroInsights helps investors, industry executives and the public understand and profit from the rapid growth of drug, device and diagnostic companies treating brain and nervous system-related illnesses - providing:

Industry Analysis

Events and Conferences

Strategic Advisory Services

Market News

By clarifying the research breakthroughs and competitive dynamics across market segments, NeuroInsights enables investors and executives to see the fastest growing sectors, develop long-term investment strategies, and analyze comparables across the $120 billion global industry. For further information visit www.neuroinsights.com.

Report Chapters Include:

01 Executive Summary 02 Trends and Drivers 03 Neuropharmaceutical Sector 04 Neurodevice Sector 05 Neurodiagnostic Sector 06 Private Neurotech Investment 07 Public Neurotech Investment 08 Leading Research Centers 09 Leading Neurotechnology Regions 10 Company Profiles List of Figures

Companies In the Report Include:

- 4-D NeuroImaging - 7TM Pharmaceuticals - Abbey Pharmaceuticals - Abbott Laboratories - Abmaxis - AC Immune - Acadia Pharmaceuticals - Accera, Inc. - Accuray - Acorda - Acta Vascular - Acumen Pharmaceuticals - Addex Pharmaceuticals - Adenosine Therapeutics - Aderis Pharmaceuticals - Adlyfe - Adolor - Advanced Bionics - Advanced Brain Monitoring - Advanced Cochlear Systems - Advanced Neuromodulation Systems - Aegera Therapeutics - Aeolus - Affectis Pharmaceuticals - Afferent - Afferon - AGY Therapeutics - Alamo Pharmaceuticals - Alexza - AlgoRx Pharmaceuticals - Algos Therapeutics - Alinea Pharmaceuticals - Alkermes - Allon Therapeutics - Alnylam - Alpha Omega Engineering - Alsius - Alza - Amarin - Ambit - Amrex Electrotherapy - Amsterdam Molecular Therapeutics (AMT) - Anagen Therapeutics - Androclus Therapeutics - Ansata Therapeutics - Antigenics - Apeiron Biologics - Apologic, Inc - Applied NeuroSolutions - Arachnova - Arena - Argolyn Bioscience - Ariston - ArmaGen - Armstrong Healthcare - Asilomar - Aspect Medical Systems - Aspreva - AstraZeneca - Astro-Med - Athena Diagnostics - Athersys - Auris Medical - Avanir - Aventis - Avera - Avicena Group - Avid Radiopharmaceuticals - Avigen - Axaron - AxoGen - Axon Neuroscience - Axonyx - Azevan - Bayhill Therapeutics - BIAL - Bioalvo - BioArctic Neuroscience - BioAxone - BioControl Systems - Biocortech - BioFrontera - Biogen Idec - BioLineRX - Bio-logic Systems - BioMS - Boehringer Ingelheim - Boston Life Sciences - Boston Scientific - Bradley Pharmaceuticals - Brain Resource Company - BrainCells - BrainLAB - BrainsGate - BrainStorm Cell Therpeutics - BrainZ - Bristol-Myers Squibb - Brittania Pharmaceuticals - Cadwell Laboratories - Cambria Bioscience - Cambridge Laboratories - Cannasat Therapeutics - Capsant Neurotechnologies - Cara Therapeutics - Carlsson Research - CellCure Neurosciences - CellMed - Cellzome - CeNeRx - CeNeS Pharmaceuticals - Cephalon - Ceptor - Cerebral Vascular - Cerebricon - Ceregene - Cerimon Pharmaceuticals - Chiesi Farmaceutici - Chondrogene - Chronogen - Clarus Medical - Clera - Cleveland Medical - CNS Response - CoAxia - Cochlear, Ltd. - Cogmed - Cognetix - Cognitive Pharmaceuticals - Cognosci - CogState - CoMentis - Compumedics, Ltd. - Concentric Medical - ConMed - ConoGenetix biosciences - Corcept Therapeutics - Cordis - Cortech - Cortex - CPS Innovations - CTI Molecular Imaging - Curidium - Curis - Cyberkinetics - Cyberonics - Cypress Bioscience - DarPharma - Descartes Therapeutics - DOV Pharmaceutical - D-Pharm - DrugAbuse Sciences - Durect - Dynogen - EEG Spectrum - Eisai - Ekos - Ekos - Elan - Elbion - Electrical Geodesics - Elekta - Eli Lilly - Ellipsis - Embera - Endo Pharmaceuticals - Enhance Biotech - Enkam - eNOS - Enpath - EnteroMedics - Entropin - EnVivo - Envoy Medical - Epic Biosonics - EpiCept - Epix - Ester Neurosciences - Eunoe - ev3 - Everest Biomedical - Evotec - ExonHit - Eyetech Pharmaceuticals - Fabre-Kramer Pharmaceuticals - Faust Pharmaceuticals - FoldRx - Forest Laboratories - Galenea www.galenea.com - Galileo - GE Healthcare - Gemacbio - GenPath - GentCorp - Geron - GI Dynamics - GlaxoSmithKline - Guilford Pharmaceuticals - GW Pharmaceuticals - Hamilton Pharmaceuticals - Helicon Therapeutics - Hunter-Fleming - Hydra Biosciences - Hypnion - i3 Research - Icagen - Icogenix - IIP-Technologies (IMI Intelligent Medical Implants) - Imagine Pharmaceuticals - ImaRx - IMI Intelligent Medical Implants - Immusol - Indena - Indevus - Ingenium - Innercool Therapies - Inotek - Integra - Intra-Cellular Therapies - Intrapace - Ionix - Janssen - Jazz Pharmaceuticals - JDS Pharmaceuticals - Johnson & Johnson - Juvantia - Kadmus - KAI Pharmaceuticals - Kaleidos - Kalypsys - KeyNeurotek - Kinexis - Knopp Neurosciences - Kosei (CNS Sub of Sosei) - Krenitsky - LA MONT Medical - Leptos - Lexicor - Lundbeck - M's Science - Maas Biolab - Magstim - MAP Medical Technologies - MAP Pharmaceuticals - Marinus - MedCool - MED-EL - Medimod - MedImpulse - MediVance - Medivation - MedPointe Pharmaceuticals - Medtrode - Medtronic - Memory Pharmaceuticals - Merck - Metabolon - Metaphore Pharmaceuticals - Micro Therapeutics - MicroCHIPS, Inc. - MicroStrain - MicroVention - Micrus - Migenix - MIICRO - MindCare Centres - MindGuard - Mindsense - Mindset - Mithridion - Mitsubishi Pharma - Moberg Medical - Molecular Neuroimaging - Molecular Synthetics - MRC Systems - Muscagen - NanoDel Technlogies GmbH - Nastech - NDI Medical - Neural Intervention Technologies - Neural Signals, Inc. - NeuraLieve - Neuralynx - Neuraxo - Neuraxon - Neuren - Neurim Pharmaceuticals - Neurion - Neuro Kinetics - Neuro3d - Neurobiological Technologies - Neurobiomed - NeuroBionics - NeuroBiotec - Neurochem - NeuroControl Corp. - Neurocrine - NeuroCure, Ltd. - Neurodan - Neurodyne - Neurofit - Neurogen - NeurogenomeX - NeurogesX - Neurognostics - NeuroHealing - NeuroLogic - Neurologics - Neurologix - Neurome - NeuroMed - NeuroMetrix - Neuromolecular - Neuronautics - Neuronax - Neuronetics - Neuronetrix - NeuroNexus - NeuroNova - Neuronyx - Neuronz - NeuroPace - Neuropharma AB - Neuropharma SA - NeuroPhysics - NeuroProfile - NeuroRecovery - Neuroscan - NeuroSearch - NeuroSonix - Neurosurvival Technologies - Neurotech SA - NeuroTherapeutics Pharma - Neurotrax - Neurotrophic Bioscience - Neurotune - NeuroVasx - New River - NewNeural - Newron Pharmaceuticals - Nicolet Biomedical - Nihon Kohden - NitroMed - Northstar Neuroscience - Novartis - Novasite Pharmaceuticals - NovaVision - Novosis - NPS Pharmaceuticals - NSGene - NuPathe - Nura - Nymox Corporation - Odin Medical Technologies - Odyssey Pharmaceuticals - Olympus 124 - Optima Neuroscience - Optobionics - Orexigen - Organon - Orphan Medical - Ortho-McNeil Pharmaceuticals - Oryx Pharmaceuticals - Ovation Pharmaceuticals - Oxford Instruments - OXIS - Pain Therapeutics - PainCeptor - Paion AG - Palatin - Palomar - Panacea - Pathogenics Inc - Pentech - Pfizer - Pharmacopeia - PharmaFrontiers - Pharmalytics - Pharmaxon - Pharmos - Pherin - Philips Medical Systems - PhotoThera - Physiometrix - Phytopharm - Plexon - Posit - Positron Corporation - POZEN - Prana - Predix Pharmaceuticals - Prescient - Prestwick - PrioSense, Ltd - Probiodrug AG - Proneuron - Proteotech - Proximagen - Psychiatric Genomics - Psychogenics - Psylin Neurosciences - Psynova - Purdue Pharma - Questcor - Radiant Medical - Radionics - Rancan Impex - Reata - Reckitt Benckiser - Regenecor - Regeneron - reMYND - ReNeuron - Renovis - Repligen - RetinaPharma - Rhinocyte - Rinat Neuroscience - Rivanna - Roche - Ruxton Pharmaceuticals - Sabine Neurotechnology - Saegis - Sanofi-Aventis - Satiety - Savient - Schering-Plough - Schwartz Pharmaceuticals - Scientific Learning - Scion - Seacoast Technologies - Second Sight - Selva Medical - Senexis - Sention - Sepracor - Serenix - Shire - Siemens - Siena Biotech S.p.A. - Sigma-Tau Pharmaceuticals - Signum Biosciences - Sirna - SleepMed - Solstice - Somatocor Pharmaceuticals - Somaxon - Somerset Pharmaceuticals - Sound Pharmaceuticals - Spectrum - Spencer Technologies - St Jude Medical - St. Croix Medical - Stem Cell Therapeutics - StemCells, Inc. - Stereotaxis - Sterix - Synaptic Pharmaceutical - Synaptica - Synarc - Synergia - Synosia - Talisker - Targacept - The Genetics Company - Theraptosis - TheraQuest Biosciences - Theravance - Thiakis - Thuris - Titan - toBBB - Toennies - TorreyPines Therapeutics - Touch EMAS - Transition - TransMolecular - TransTech - Tranzyme - Trophos - Tucker-Davis - UCB - Valeant - Valera - Vanda - Varian - Vasogen - Vela Pharmaceuticals - Vernalis - VIASYS - VIATRIS - Victhom Human Bionics - Vistagen - Voyager - VSM Medtech - Wellstat - Wicab - Wyeth - Xcel - Xenome - Xenon - Xenoport - Xenova Group - Xention - Xigen - Xsira - Xytis - Yaupon - Zapaq - Zogenix - Zyentia - Zynex

For more information visit http://www.researchandmarkets.com/reports/c59269

Source: Business Wire

More News in this Category